P2029 Congo red blood test
Also known as: Congo red test, Amyloid screening
Congo red blood test, used historically to assess liver disease and amyloidosis.
In Plain Language
Congo red staining test
Clinical Context
Historical diagnostic test for liver disease and amyloid protein detection, now largely obsolete with modern testing methods.
RVU Information
CPT P2029 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
P-codes cover pathology screening and blood product services. Documentation must include the ordering provider, clinical indication, and specimen type. For blood products, include the product type, volume, and transfusion details.
Specialties
Frequently Asked Questions
What is CPT code P2029?
CPT P2029 (Congo red blood test) is a P Codes code. Congo red blood test, used historically to assess liver disease and amyloidosis.
Does Medicare cover P2029?
Medicare coverage for P2029 depends on medical necessity and applicable Local Coverage Determinations (LCDs). Historical diagnostic test for liver disease and amyloid protein detection, now largely obsolete with modern testing methods. A physician order is typically required.
When is CPT P2029 used?
Historical diagnostic test for liver disease and amyloid protein detection, now largely obsolete with modern testing methods.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.